Stocktoria

Liquidia Corp LQDA

Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 2018-07-26
Chart by TradingView
3/9
Piotroski F — financial health
-4.36
Altman Z″ — distress risk · distress
Dividend payout · no dividend

Valuation · market cap as of 2026-06-29

Market cap$7.0B
P / S43.9×

Financials & ratios (annual, from 10-K)

MetricFY2025FY2024FY2023FY2022FY2021
Financials
Revenue$158.3M$14.0M$17.5M$15.9M$12.9M
Operating income-$51.4M-$121.3M-$73.4M-$38.8M-$33.8M
Net income-$68.9M-$128.3M-$78.5M-$41.0M-$34.6M
Operating cash flow-$35.7M-$93.4M-$41.6M-$28.6M-$34.0M
Free cash flow-$40.0M-$98.4M-$42.9M-$29.2M-$34.1M
Total assets$327.9M$230.3M$118.3M$129.2M$93.7M
Total liabilities$283.2M$150.9M$71.0M$38.8M$28.5M
Shareholders' equity$44.7M$79.4M$47.3M$90.4M$65.3M
Ratios
Operating margin-32.5%-866.6%-419.6%-243.3%-263.0%
Net margin-43.5%-916.6%-448.9%-257.4%-269.0%
FCF margin-25.3%-702.9%-245.0%-183.1%-265.6%
Return on assets-21.0%-55.7%-66.3%-31.7%-36.9%
Return on equity-154.0%-161.6%-166.0%-45.4%-53.0%
Debt / equity0.22×0.16×
Current ratio2.014.434.8511.348.36
Revenue growth1031.2%-20.0%9.7%24.0%1637.8%

Notable holders (13F)

InvestorSharesValue
RENAISSANCE TECHNOLOGIES LLC8,100$305,694

Why these scores methodology →

Piotroski F-score: 3/9

  • Positive return on assets
  • Positive operating cash flow
  • Rising ROA
  • Cash flow exceeds net income
  • Lower long-term debt
  • Rising current ratio
  • No share dilution
  • Rising gross margin
  • Rising asset turnover

Altman Z″: -4.36 (distress)

  • Working capital / assets 0.42
  • Retained earnings / assets -1.91
  • EBIT / assets -0.157
  • Equity / liabilities 0.158

Sector peers

VFS · TM · HMC · SONY · AAPL · XOM · all Manufacturing →

Source: SEC EDGAR filings · CIK 0001819576 · as of 2025-12-31. Figures are facts from filings plus Stocktoria's own computed scores — not investment advice.